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We report eight cases of airway colonization by Geosmithia argillacea in patients
with cystic fibrosis. This filamentous fungus, resembling members of the genera
Penicillium and Paecilomyces, was identified by molecular analysis. All patients
carried a mutation on each CFTR (cystic fibrosis transmembrane conductance
regulator) allele, with at least one copy of the F508del mutation. The first isolation
of this fungus occurred from F508del-homozygous patients at a younger age than in
F508del-heterozygous patients. Before recovery of G. argillacea, all patients were
treated with itraconazole; two of them had also received voriconazole for an
Aspergillus fumigatus infection. However, antifungal susceptibility patterns showed
high MICs of voriconazole for all isolates, and high MICs of amphotericin B and
itraconazole for the majority of them, but mostly low minimum effective
concentrations (MECs) of caspofungin. The appearance and persistence of G.
argillacea in the airways were not associated with exacerbation of the disease.
However, the clinical implications of G. argillacea, particularly in
immunocompromised patients, remain a concern, particularly given recent
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